Loading...

June 2021

Award of a two year EUREKA Eurostars grant, together with Eodyne SA, on development of data analytics and decision support tools for rehabilitation of stroke patients

January 2021

Two collaboration studies published: Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients (Abdul-Jawad et al, Cancer Cell, and Genetic risk, lifestyle, and age-related macular degeneration in Europe, Colijn et al, Ophthalmology)

November 2020

Award of a five year CRUK consortium grant on early detection of head and neck cancer, with Saddle Point Science as data analytics partner

June 2020

Replica analysis of overfitting in generalized linear models published (Coolen et al, Journal of Physics A)

March 2020

Start of a formal collaboration with Bit Bio (Cambridge) and LIMS (London) on the mathematical modellling of cell reprogramming

January 2020

HER2-HER3 heterodimer quantification by FRET-FLIM and patient subclass analysis of the COIN colorectal trial published (Barber et al, Journal of the National Cancer Institute) - first proof of principle of the ability of Saddlepoint Mosaics to identify responder subgroups in failed clinical trials ...

October 2019

Analysis of overfitting in the regularized Cox model (Sheikh and Coolen, Journal of Physics A)

March 2019

Accurate Bayesian data classification without hyperparameter cross-validation (Sheikh and Coolen, Journal of Classification)

November 2018

The SaddlePoint Signature analytics pipeline is installed at Erasmus Medical Center Rotterdam (Dept of Epidemiology).

August 2018

Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus (Haggstrom et al, Int J Cancer)

July 2018

the EU consortium RGS@home, in which SaddlePoint Science is the analytics partner, has been awarded an EIT Health grant (ranked 2nd out of 175 applications). RGS@home will start early 2019.​

Let's discuss what we can do for you.